About: http://data.cimple.eu/news-article/5abc2ac933ee3c2a707de0ec7545abb0741600d5e3353c88a4811180     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : schema:NewsArticle, within Data Space : data.cimple.eu associated with source document(s)

AttributesValues
rdf:type
schema:articleBody
  • Russian authorities on Tuesday said mass production of its second coronavirus vaccine would begin next month and that a third homemade jab is currently in registration. Russia launched an inoculation campaign earlier this month, making its first homegrown vaccine, Sputnik V, available to all citizens 18 and older. Sputnik V was registered in August -- months ahead of Western competitors -- and a second Covid vaccine, EpiVacCorona, swiftly followed in October. "Next month we will move on to a large-scale release of the EpiVacCorona vaccine," Prime Minister Mikhail Mishustin told a cabinet meeting Tuesday. "It has already started to become available to the public," he added, noting the government has allocated two billion rubles ($26.5 million) to produce the jab. EpiVacCorona was developed by Vektor, a top-secret laboratory in the Siberian city of Novosibirsk that stockpiles viruses ranging from Ebola to smallpox. Its coronavirus vaccine triggers an immune response using synthetic virus proteins, while Sputnik V uses adapted strains of the adenovirus, a virus that causes the common cold. Russia's health regulator Rospotrebnadzor this month said early stage trials had shown EpiVacCorona to be 100 percent effective. Russia has said that it will be able to inoculate 60 percent of the population this year, though rollout of Sputnik V has been slower than planned. Health Minister Mikhail Murashko told the cabinet his ministry was in the process of registering a third homemade coronavirus vaccine. He added that the jab would be made available to the public "within a month". Total infections stood at more than 3.7 million on Tuesday, making Russia's caseload the fourth-highest in the world. emg/acl/bp
schema:headline
  • Russia to mass produce second Covid vaccine next month
schema:mentions
schema:author
schema:datePublished
http://data.cimple...sPoliticalLeaning
http://data.cimple...logy#hasSentiment
http://data.cimple...readability_score
http://data.cimple...tology#hasEmotion
Faceted Search & Find service v1.16.115 as of Oct 09 2023


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 07.20.3238 as of Jul 16 2024, on Linux (x86_64-pc-linux-musl), Single-Server Edition (126 GB total memory, 5 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software